These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 37525044)
1. Cognitive Rehabilitation for Patients with Schizophrenia: A Narrative Review of Moderating Factors, Strategies, and Outcomes. Skokou M; Messinis L; Nasios G; Gourzis P; Dardiotis E Adv Exp Med Biol; 2023; 1423():193-199. PubMed ID: 37525044 [TBL] [Abstract][Full Text] [Related]
2. Modafinil for people with schizophrenia or related disorders. Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767 [TBL] [Abstract][Full Text] [Related]
3. [Cognitive remediation and cognitive assistive technologies in schizophrenia]. Sablier J; Stip E; Franck N Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385 [TBL] [Abstract][Full Text] [Related]
4. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review. Saavedra-Velez C; Yusim A; Anbarasan D; Lindenmayer JP J Clin Psychiatry; 2009 Jan; 70(1):104-12. PubMed ID: 19026265 [TBL] [Abstract][Full Text] [Related]
5. [Cognition, schizophrenia and the effect of antipsychotics]. Stip E Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928 [TBL] [Abstract][Full Text] [Related]
7. Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Eack SM; Greenwald DP; Hogarty SS; Cooley SJ; DiBarry AL; Montrose DM; Keshavan MS Psychiatr Serv; 2009 Nov; 60(11):1468-76. PubMed ID: 19880464 [TBL] [Abstract][Full Text] [Related]
8. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Keefe RS; Silva SG; Perkins DO; Lieberman JA Schizophr Bull; 1999; 25(2):201-22. PubMed ID: 10416727 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment. Bosia M; Zanoletti A; Spangaro M; Buonocore M; Bechi M; Cocchi F; Pirovano A; Lorenzi C; Bramanti P; Smeraldi E; Cavallaro R Psychiatry Res; 2014 Jun; 217(1-2):9-14. PubMed ID: 24656901 [TBL] [Abstract][Full Text] [Related]
10. New Pharmacological Targets for the Treatment of Schizophrenia: A Literature Review. Ventriglio A; Bellomo A; Ricci F; Magnifico G; Rinaldi A; Borraccino L; Piccininni C; Cuoco F; Gianfelice G; Fornaro M; Delle Monache S; De Berardis D Curr Top Med Chem; 2021 Oct; 21(16):1500-1516. PubMed ID: 34218785 [TBL] [Abstract][Full Text] [Related]
11. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. Freudenreich O; Henderson DC; Macklin EA; Evins AE; Fan X; Cather C; Walsh JP; Goff DC J Clin Psychiatry; 2009 Dec; 70(12):1674-80. PubMed ID: 19689921 [TBL] [Abstract][Full Text] [Related]
12. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders Aust N Z J Psychiatry; 2005; 39(1-2):1-30. PubMed ID: 15660702 [TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
14. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. Kirkman MA; Day J; Gehring K; Zienius K; Grosshans D; Taphoorn M; Li J; Brown PD Cochrane Database Syst Rev; 2022 Nov; 11(11):CD011335. PubMed ID: 36427235 [TBL] [Abstract][Full Text] [Related]
15. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Woodward ND; Jayathilake K; Meltzer HY Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785 [TBL] [Abstract][Full Text] [Related]
18. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Stip E; Tourjman V Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550 [TBL] [Abstract][Full Text] [Related]
19. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Meltzer HY; McGurk SR Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729 [TBL] [Abstract][Full Text] [Related]